KIRN DAVID (See Remarks) sold 7.6% of their position (58.33K shares) of 4D MOLECULAR THERAPEUTICS, INC. on the open market
Open‑market sale worth $753.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/7/2026ACC: 0001193125-26-417068
DirectorOfficer10% Owner· See Remarks
Since Dec 2020
-58.33K
Net shares
Net seller
$753.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
58.33K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−58.06K
Price / share
$12.92
Trade value
$750.24K
% of position
7.6%
10/5/2026
767.49K→709.42K
Common Stock
Direct
Shares
−272.00
Price / share
$13.61
Trade value
$3.70K
% of position
0.0%
10/5/2026
709.42K→709.15K
Total
Net shares
−58.33K
Net value
-$753.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/5/2026 | S · Sale | −58.06K | $12.92 | $750.24K | 7.6% | 767.49K | 709.42K |
| Common Stock Direct | 10/5/2026 | S · Sale | −272.00 | $13.61 | $3.70K | 0.0% | 709.42K | 709.15K |
| Total | −58.33K | -$753.94K | ||||||
Derivative Transactions0
No derivative transactions reported